Have any questions? 706-721-6582 or cts@augusta.edu
| Study Name | Principal Investigator |
|---|---|
| MORAb-202-G000-201: A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a folate receptor alpha (FR?)-targeting antibody-drug conjugate (ADC) in Subjects With Selected Tumor Types | Ghamande, Sharad |
| S1827, | Ghamande, Sharad |
| S1929, | Raval, Girindra |
| S1933, | Raval, Girindra |
RESEARCH. INNOVATION. DISCOVERY.